The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Committee on Rheumatologic Care Helps Establish Principles & Position Statements

Committee on Rheumatologic Care Helps Establish Principles & Position Statements

December 5, 2018 • By Carina Stanton

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR’s Committee on Rheumatologic Care (CORC) has been busy on many fronts, including establishing new position statements for the College, introducing new practice perspectives and engaging multiple stakeholders in actions to protect and enhance rheumatology practice, such as with payers.

You Might Also Like
  • ACR Issues Position Statements on Key Rheumatology Issues
  • ACR Releases New Position Statements on Site of Service & Compounding
  • ACR Puts Forward Principles on Patient Access to Care
Also By This Author
  • Uveitis: Know the Risk Factors, Symptoms & Treatment Options

“CORC ensures the rheumatology voice is heard in all of the most critical venues,” says CORC Chair Colin Edgerton, MD, FACP, RhMSUS. “Communication with our ACR members, government agencies, payers and other stakeholders is robust and timely, focusing on patient access and practice success.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

CORC Takes Action
Dr. Edgerton shares several key activities that members of CORC have been engaged in this year on behalf of the rheumatology community of providers and patients:

  1. Engaging new voices in practice advocacy

CORC established a new standing member position for a pharmacist.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We anticipate that Andrew Hochradel, PharmD, our CORC pharmacist member, will be invaluable in assisting with analysis and responses to the many drug-pricing initiatives coming from the current administration,” Dr. Edgerton says.

  1. Taking an even stronger stand on drug pricing

CORC has collaborated with the ACR’s Government Affairs Committee and Board of Directors as part of a drug-pricing workgroup to draft the “ACR Principles on Prescription Drug Prices and Access to Treatment.” These principles reinforce the ACR’s position on patient access to safe and effective treatments at the lowest possible cost, and supports evidence-based policies and shared decision-making to support this access to care.

“This document tackles the challenges of drug pricing and access barriers. It will inform ACR responses to administration drug pricing proposals, including the Competitive Acquisition Program and the International Pricing Index notification,” Dr. Edgerton says.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
  1. Speaking directly with payers

Through CORC’s Insurance Subcommittee (ISC), chaired by Christopher Phillips, MD, CORC members continue to communicate with members and payers on numerous issues, including site-of-service restrictions on infused biologics and modifier 25 payment reduction policies.

“CORC was cautiously optimistic to see UnitedHealthcare hold off on formally announcing elimination of consultation codes and reducing reimbursement for E/M services by 25% when billed with a modifier 25,” Dr. Edgerton notes.

  1. Formalizing positions on key practice issues

In 2018, CORC established seven new position statements that impact access and coverage, treatment, and the role of rheumatology. These ACR position statements serve as official statements that reflect the position of the College. Position statements introduced by CORC this year include:

  • Beers List—Outlines the ACR’s opposition to the Beers criteria, which do not account for individual diagnoses, signs, symptoms or disease severity, or for pharmaceutical formulary decisions, punitive measures or quality ratings for individual providers.
  • Biosimilars—Reinforces the idea that decisions regarding the approval and use of biosimilars be driven by evidence and take into account such factors as stronger analytical evaluation, clinical data and post-market surveillance.
  • Medicare Recovery Audit Contractors—Supports changes implemented by the CMS regarding the auditing structure of Medicare claims.
  • Use of Diagnostic Imaging in Rheumatology Practice—Supports the ordering, performance and interpretation of imaging studies of the musculoskeletal system as an integral part of the rheumatology practice.
  • Musculoskeletal Ultrasound—Supports the use of, training for and appropriate reimbursement for this imaging technique in rheumatology care.
  • Pharmacovigilance—Supports robust pharmacovigilance to ensure the safety of medications used in rheumatology through federal reporting mechanisms, more thorough reporting of adverse events and improved access to pharmacovigilance systems.
  • Copay Accumulator—Addresses the new insurance practice of not allowing copay assistance to count toward a patient’s deductible, thereby increasing out-of-pocket costs for patients while reducing access to therapy. “CORC was pleased to see this position statement approved by the Board of Directors this October at the ACR/AHRP Annual Meeting,” Dr. Edgerton noted.

Want to Know More?
Dr. Edgerton suggests the best way to keep up with CORC activities is to follow the ACR’s Advocacy News on the ACR website.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy Tagged With: ACR Principles on Prescription Drug Prices and Access to Treatment, Committee on Rheumatologic Care (CORC), new position statements, standing member position

You Might Also Like:
  • ACR Issues Position Statements on Key Rheumatology Issues
  • ACR Releases New Position Statements on Site of Service & Compounding
  • ACR Puts Forward Principles on Patient Access to Care
  • ACR Puts Forward Principles on Patient Access to Care

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.